Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability
Authors:
- 28 August 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 31 (2) , 729-739
Abstract
Objectives Comparing the diagnostic efficacy of diffusion kurtosis imaging (DKI) derived from different region of interest (ROI) methods in tumor parenchyma for grading and predicting IDH-1 mutation and 1p19q co-deletion status of glioma patients and correlating with their survival data. Methods Sixty-six patients (29 females; median age, 45 years) with pathologically proved gliomas (low-grade gliomas, 36; high-grade gliomas, 30) were prospectively included, and their clinical data were collected. All patients underwent DKI examination. DKI maps of each metric were derived. Three groups of ROIs (ten spots, ROI-10s; three biggest tumor slices, ROI-3s; and whole-tumor parenchyma, ROI-whole) were manually drawn by two independent radiologists. The interobserver consistency, time spent, diagnostic efficacy, and survival analysis of DKI metrics based on these three ROI methods were analyzed. Results The intraexaminer reliability for all parameters among these three ROI methods was good, and the time spent on ROI-10s was significantly less than that of the other two methods (p < 0.001). DKI based on ROI-10s demonstrated a slightly better diagnostic value than the other two ROI methods for grading and predicting the IDH-1 mutation status of glioma, whereas DKI metrics derived from ROI-10s performed much better than those of the ROI-3s and ROI-whole in identifying 1p19q co-deletion. In survival analysis, the model based on ROI-10s that included patient age and mean diffusivity showed the highest prediction value (C-index, 0.81). Conclusions Among the three ROI methods, the ROI-10s method had the least time spent and the best diagnostic value for a comprehensive evaluation of glioma. It is an effective way to process DKI data and has important application value in the clinical evaluation of glioma. Key Points • The intraexaminer reliability for all DKI parameters among different ROI methods was good, and the time spent on ROI-10 spots was significantly less than the other two ROI methods. • DKI metrics derived from ROI-10 spots performed the best in ROI selection methods (ROI-10s, ten-spot ROIs; ROI-3s, three biggest tumor slices ROI; and ROI-whole, whole-tumor parenchyma ROI) for a comprehensive evaluation of glioma. • The ROI-10 spots method is an effective way to process DKI data and has important application value in the clinical evaluation of glioma.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2017A030313676)
This publication has 32 references indexed in Scilit:
- Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensitiesEuropean Radiology, 2013
- IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular MorphologyPLOS ONE, 2013
- Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation statusEuropean Radiology, 2012
- MR diffusion kurtosis imaging for neural tissue characterizationNMR in Biomedicine, 2010
- Towards better MR characterization of neural tissues using directional diffusion kurtosis analysisNeuroImage, 2008
- Apparent diffusion coefficients in oligodendroglial tumors characterized by genotypeJournal of Magnetic Resonance Imaging, 2007
- Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumorsActa Neuropathologica, 2005
- Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imagingMagnetic Resonance in Medicine, 2005
- Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 casesJournal of Neurosurgery, 2005
- Histopathology, classification, and grading of gliomasGlia, 1995